> ANI Pharmaceuticals beefed up its generics portfolio with Teva ($TEVA) deal. Release
> Taiwan's TWi hired a Teva executive after breaking with Israeli firm on U.S. marketing plans. Release
> TWi Biotechnology got a Taiwan FDA nod for rare drug designation on its candidate for treating epidermolysis bullosa simplex. Release
> Japan's Astellas won a FDA nod on Cresemba. Release
> Japan's Shimadzu is looking past China for Asian growth with Southeast Asia in sight. Story